Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotide technology: from EST to therapeutics.

R V Giles1

  • 1Department of Haematology, Liverpool University, Life Science Building, Crown Street, Liverpool L69 7ZB, UK. giles@liv.ac.uk

Current Opinion in Molecular Therapeutics
|March 16, 2001
PubMed
Summary

Antisense oligonucleotides offer powerful gene silencing for research and disease treatment. This review covers sequence selection, mechanisms, delivery, and future applications of this promising technology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of c-myc is not critical for cell proliferation in established human leukemia lines.

BMC molecular biology·2001
Same author

Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.

Nucleic acids research·2001
Same author

The direction of ribonucleases H by antisense oligodeoxynucleotides.

Methods in molecular biology (Clifton, N.J.)·2001
Same author

Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells.

Blood·2000
Same author

Oligodeoxynucleotide 5mers containing a 5'-CpG induce apoptosis through a mitochondrial mechanism in T lymphocytic leukaemia cells.

Nucleic acids research·2000
Same author

Chimeric oligodeoxynucleotide analogs: chemical synthesis, purification, and molecular and cellular biology protocols.

Methods in enzymology·1999

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Antisense oligonucleotides (ASOs) represent a significant advancement in molecular biology.
  • Selective gene expression inhibition holds potential for both fundamental research and therapeutic applications.

Purpose of the Study:

  • To review cell culture-based research on antisense oligonucleotide technology.
  • To discuss selection of optimal effector sequences, mechanisms of action, and intracellular delivery.
  • To examine preclinical and clinical applications and future directions of ASO technology.

Main Methods:

  • Literature review of cell culture-based studies.
  • Analysis of ASO mechanisms, including sequence-specific and non-specific effects.
  • Evaluation of ASO delivery methods into cellular compartments.
  • Review of preclinical and clinical data on ASO applications.

Main Results:

  • Optimal antisense effector sequences can be selected using cell culture models.
  • ASOs exhibit both desired sequence-specific and non-antisense mechanisms of action.
  • Effective delivery into intracellular compartments is crucial for ASO function.
  • Preclinical and clinical studies demonstrate the therapeutic potential of ASOs.

Conclusions:

  • Antisense oligonucleotide technology is a rapidly advancing field with significant implications for biological research and medicine.
  • Continued research promises highly productive future applications in functional genomics and disease treatment.
  • The development of ASOs offers a powerful tool for targeted gene modulation.

Related Experiment Videos